Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emily G. Barr Fritcher
Antitumor Effect of FGFR Inhibitors on a Novel Cholangiocarcinoma Patient Derived Xenograft Mouse Model Endogenously Expressing an FGFR2-CCDC6 Fusion Protein
Cancer Letters
Cancer Research
Oncology
Related publications
PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
The Specific Serotonin Reuptake Inhibitors Sertraline and Fluoxetine Promote Tumor Growth in a Mouse Xenograft Model of Cholangiocarcinoma
Matters
Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC
Cancer Research
Cancer Research
Oncology
HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma
Hepatology
Medicine
Hepatology
Patient-Derived Cancer Xenograft Xebrafish Model (PDXZ) and Personalized Medicine
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Derazantinib (ARQ 087) in Advanced or Inoperable FGFR2 Gene Fusion-Positive Intrahepatic Cholangiocarcinoma
British Journal of Cancer
Cancer Research
Oncology
Antitumor Activity of T Cells Reactive Against Cytomegalovirus-Infected Cells in a Mouse Xenograft Tumor Model
Cancer Research
Cancer Research
Oncology
Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Development of a Patient-Derived Xenograft Model of Glioblastoma via Intravitreal Injection in Mice
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
